Nanomedicine & Fullerene Chemistry

Progress in nanomedicine resulted in numerous scientific papers, studies, and several promising clinical trials, but only a few clinically-approved nanodrugs. There is a growing sentiment in the field that we can do more than that. I​n order to increase the availability of nanodrugs for patients, we need to address the biological, pathophysiological, immunological and manufacturing/regulatory barriers to effective translation into the clinic.

The goals of the two day Mechanisms and Barriers in Nanomedicine workshop are to:

  • Provide an educational forum on the barriers to nanoparticle translation;
  • Provide a paradigm shift to overcome these problems; and
  • Allow for open discussion among faculty, postdocs and graduate students, to trigger new ideas and concepts.

The workshop will consist of informal, non-concurrent sessions, followed by discussion. Talks will focus on mechanisms, problems, and solutions of the following aspects of nanomedicine:

  • Bio-nano interface, immune recognition, and toxicity
  • Complement
  • ​In vitro and in vivo barriers
  • ​No-engineering and design
  • ​Metastatic cells, stem cells, and relevance of mouse models
  • Regulatory/industrial hurdles
  • Carbon Nanotubes - From Fundamentals to Devices
  • Graphene and Beyond - 2D Materials
  • Impact of nanotechnology on drug delivery
  • Inorganic/Organic Nanohybrids for Energy Conversion
  • Carbon allotropes
  • Fullerene purification
  • Pharmaceuticals and personal care products
  • The chemistry of tissue adhesive materials
  • Synthetic chemistry of nanomaterials

Related Conference of Nanomedicine & Fullerene Chemistry

Nanomedicine & Fullerene Chemistry Conference Speakers